This study intends to unfurl the multiple facets of global microbial identification market. The insights offered in the report aid in market growth examination during the forecast period.
Surging Prevalence of Infectious Diseases Will Uphold Microbial Identification Market Growth
The increasing prevalence of infectious diseases, technological developments in microbial identification, rising concerns about food safety, and government initiatives and funding for improving microbial identification are some factors driving the expansion of microbial identification market. The primary factor fueling market expansion is the rise of infectious diseases. For instance, the World Health Organization's (WHO) Global Tuberculosis Report 2021 data shows that the majority of tuberculosis cases were found in South-East Asia (43%), Africa (25%), and the Western Pacific (18%), while the Eastern Mediterranean (8.3%), the Americas (3.0%), and Europe (2.3% saw less of a rise in cases. Thus, it is anticipated that increasing infectious disease incidences will boost demand for microbiological testing and drive rapid market growth.
The expanding worries about food safety in packaged and unpackaged foods fuel industry expansion. The population is increasingly moving toward eating processed foods, which carry a significant risk of microbial contamination. For instance, it was discovered that 80% of Australian adults regularly consumed processed or junk food, such as mass-produced ready meals, packaged bread, fast food dishes, and buns, pastries, and cakes, according to an article published in December 2020 by Nutrition and Diabetes, titled, ‘Ultra-processed food consumption and obesity in the Australian adult population’. It is thus anticipated that the population's large consumption of this processed food would raise the need for microbiological testing to provide safe and high-quality food to the general public. This is expected to drive the growth of microbial identification market.
Microbial Identification Market: COVID-19 Impact
The world health agency declared COVID-19 as the start of healthcare, putting restrictions on national lockdown and prohibiting foreign travel. Due to the statewide lockdown, sales of the consumables and instruments needed for microbiological identification have been halted in most countries, which has had a detrimental impact on the microbial identification market. However, the market is anticipated to grow on average in the upcoming years. According to Clinical Trials.gov, MALDI-TOF MS profiling developed a sophisticated PCR-free method to locate distinctive protein signatures in human saliva during the covid-19 timeframe. As a result, the routine diagnostic use of MALDI-TOF MS profiling to find microorganisms. Additionally, the infectious status of people has been evaluated using MALDI-TOF MS profiling based on their saliva.
Growing Prevalence of Pandemics, and Rising Incidence of Infectious Diseases to Foster Microbial Identification Market Expansion
The principal use of microbial identification is the diagnosis of human diseases. It provides quick and trustworthy results that support the prompt implementation of effective medicines. Products for microbial identification can help treat infectious diseases better, especially in places with poor healthcare infrastructure. There are thought to be 1,400 pathogens that can harm humans. Approximately 350 million cases of foodborne illnesses are caused by pathogenic bacteria alone. In the U.S. alone, there are about 48 million foodborne illnesses each year, which result in 128,000 hospital admissions and 3,000 fatalities. In the world, poor water hygiene can result in 1.7 million deaths annually, with 90% of those deaths being children. However, the majority of these fatalities are reported in developing nations. The prevalence of infectious diseases around the world has significantly increased over time. According to the WHO, one of the top 10 causes of death is tuberculosis. Globally, T.B. claimed the lives of 1.5 million people in 2018. Through T.B. diagnosis and treatment between 2000 and 2018, an estimated 58 million lives were saved. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), there were 1.7 million new HIV infections, 38 million people living with the virus, and 690,000 AIDS-related deaths worldwide in 2019. Due to the high incidence of various infectious diseases and the rising frequency of pandemics, the microbial identification market is expanding.
Pharmaceutical Research Advancements to Drive Microbial Identification Market Growth
The pharmaceutical industry's success and utility are determined by its responsiveness to modern medicine's concerns. The pharmaceutical industry has embraced microbial identification to encourage innovation in drug development and research. Furthermore, pharmaceutical producers are interested in using microbial identification to examine the action of various medications on specific microorganisms. As a result, the overall volume of revenues in the global microbial identification market is expected to skyrocket. The study of human DNA and how it differs from the DNA of other species is also connected to microbial identification.
Expensive Costs of Automated Identification Technologies Limits Microbial Identification Market Growth
Automated microbiological identification tools have a hefty price tag and are outfitted with cutting-edge features and functions. A MALDI-TOF-based system might cost anywhere between US$150,000 to US$850,000. The consumables required for identification techniques are also expensive, and labor costs are also involved. Many new rapid tests are typically between US$100 and US$250; they are significantly more expensive than traditional culture techniques. For some end users, the estimated cost of the tools, media, and labor is too high. Automated microbial identification systems cost between US$50,000 and US$75,000. Because pharmaceutical companies need so many of these systems, the capital expense rises significantly. The total cost of ownership of these instruments has increased as a result of the maintenance charges as well as several other indirect expenses. This makes it more difficult for institutions, especially very small ones, to use automated microbial identification techniques widely, thereby limiting the expansion of microbial identification market.
Bacterial Identification Systems to Dominate Microbial Identification Market
Based on product, the microbial identification market is segmented into bacterial identification systems, microbial enumeration systems, bacterial resistance identification systems, microbiology analyzers, and parasitology analyzers. The bacterial identification systems held the largest market share in 2021 and are anticipated to increase significantly over the next several years. This is due to the increasing usage of bacterial identification technologies across various end-use industries. Food quality assurance and tracking bacterial pathogen outbreaks within the food chain depend heavily on the swift and accurate detection of pathogenic microorganisms isolated from food samples. In clinical and food microbiology labs, automated microbial identification technologies are increasingly employed. These systems outperform conventional methods in several crucial ways, including decreased labor requirements, a decreased risk of human error, increased sample throughput, and quicker turnaround times for test results.
Phenotypic Methods Category to Dominate Microbial Identification Market
Based on methods, the microbial identification market is segmented into phenotypic methods, proteotypic methods, and genotypic methods. The phenotypic methods category dominated the market over the forecast period. This is due to the increased use of phenotypic techniques in microbial identification. Expressed gene products are used in phenotypic approaches to differentiate between various bacteria. These techniques give microbiologists the crucial data they need to assess product risk and spot changes in the microflora of the environment. Most clinical, water, food, and pharmaceutical microbiological testing laboratories use phenotypic microbial identification techniques.
North America’s Prominenace Prevails in Microbial Identification Market Due to Increased Prevalence of Infectious Diseases
Over the forecast period, it is anticipated that the North American microbial identification market will account for the largest revenue share due to the increased prevalence of infectious diseases and epidemic outbreaks, rising healthcare costs, and well-established healthcare infrastructure. The area's primary driver of market expansion is the rising prevalence of infectious diseases. For example, according to information released by the Centers for Medicare & Medicaid Services in March 2022 under the heading "CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures", it has been noted that the annual growth in national health spending is anticipated to be 5.1% on average over the period 2021-2030. Thus, it is anticipated that rising healthcare spending will spur business activity and government attempts to create technologically cutting-edge testing tools and solutions, which will fuel market expansion. Over the course of the forecast period, rising technologically sophisticated items and the existence of significant regional market players are also anticipated to support market expansion.
The Asia Pacific microbial identification market is anticipated to experience stable revenue growth throughout the forecast period, mostly due to the growing consumer concern over their health and food safety. Furthermore, government initiatives about tainted food and water have benefited the market over time. The APAC region's market will increase due to the region's expanding healthcare infrastructure, high prevalence of infectious illnesses, expanding efforts to stop their spread, robust governmental initiatives, rising investments, and ongoing projects. Additionally, China is becoming a prominent market due to the growing prevalence of infectious diseases, which is extremely profitable for expanding the microbial identification industry.
Global Microbial Identification Market: Competitive Landscape
In May 2022, to advance its cellular analysis product portfolio, Biolog, Inc., a leading provider of microbial identification, appointed veteran Robert Wicke as CEO and Barry Bochner as a founder to develop and sell products in a variety of markets, including biotechnology, academic research, agriculture, and plant and animal health. Similarly, in June 2021, a formal agreement was made for Danaher Corporation to buy privately held Aldevron for about US$9.6 billion in cash. Danaher expects to use cash or earnings from commercial paper issues to finance the transaction.
A few of the players in the microbial identification market include Danaher Corporation, Bruker Corporation, Thermo Fisher Scientific, Siemens Healthineers, Shimadzu Corporation, QIAGEN N.V, bioMerieux S.A., Merck & Co Inc., Biolog, Inc., Becton, Dickinson and Company, Beckman Coulter, Wickham Laboratories, VWR International, LLC., MIDI Inc., Siemens Healthcare, and Charles River Laboratories Inc.
Regional Classification of Global Microbial Identification Market Can be Given as Below:
Middle East and Africa
*Regions and countries are subject to change based on data availability.
Key Elements Included In The Study: Global Microbial Identification Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.View Methodology